|
An open label, randomised, five-way crossover single-dose pharmacokinetic study to assess dosage strength equivalence of ropinirole CR in healthy male and female volunteers |
ropinirole |
101468/219 |
|
Parkinson Disease |
Phase 1 |
|
|
|
|
A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies. |
June 2014 |